Test Price
2,800 AED✅ Home Collection Available
WDR45 Gene Neurodegeneration with Brain Iron Accumulation Type 5 (BPAN) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Next Generation Sequencing (NGS) with ISO 9001:2015 Accredited Laboratory Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by qualified genetic counselors.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The WDR45 Gene Genetic Test is a definitive molecular diagnostic tool designed to detect pathogenic variants in the WDR45 gene (Xp11.23), which encodes the WD repeat domain 45 protein critical for autophagic flux in neuronal cells. Pathogenic mutations in WDR45 cause Beta-Propeller Protein-Associated Neurodegeneration (BPAN), also classified as Neurodegeneration with Brain Iron Accumulation Type 5 (NBIA5) — a rare, progressive X-linked dominant disorder characterized by global developmental delay in early childhood followed by rapid neurological deterioration, dystonia-parkinsonism, and cerebral iron deposition detectable via T2*-weighted MRI.
| Feature | Our Test — NGS WDR45 Full Gene Analysis | Closest Alternative — Single-Gene Sanger Sequencing |
|---|---|---|
| Precision / Resolution | Single-Nucleotide Variants (SNVs), Indels, Copy Number Variants (CNVs) — Full Gene Coverage | SNVs and small Indels only; limited CNV detection |
| Methodology | Next Generation Sequencing (NGS) with 100X minimum coverage depth; Variants classified per ACMG 2026 Guidelines | Capillary Electrophoresis Sanger Sequencing; Lower throughput |
| Turnaround Time | 3 to 4 Weeks (ISO-Certified Laboratory) | 6 to 8 Weeks (May require external referral) |
Physician Insight & Safety Protocols
A Clinical Note from Lina Osama Zaki Quteineh (DHA License: 9294403, Consultant Medical Genetics): "Every variant identified in the WDR45 gene must be interpreted within the full clinical and radiological context of the patient — a genetic diagnosis of BPAN is life-altering and demands multidisciplinary correlation with neurology, neuroradiology, and medical genetics. I strongly advise that no therapeutic decisions be made based on this genetic result alone without comprehensive clinical assessment."
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing neurological management; abrupt cessation of anti-epileptics, dopaminergic agents, or iron chelation therapy can precipitate serious adverse events including status epilepticus or neuroleptic malignant-like syndrome.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do NOT proceed with home collection if any apply):
- Patient is a minor (under 18 years) without documented legal guardian consent, in strict compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Active febrile illness or acute infection requiring hospitalization.
- Inability to provide valid Emirates ID or passport for identity verification.
- Recent hematopoietic stem cell transplantation (within 90 days) — may yield donor-derived DNA confounding results.
Emergency Red Flags — Seek Immediate Medical Attention:
- Acute onset dystonic crisis or status dystonicus.
- Loss of ambulation or acute neurological regression.
- Seizure activity lasting more than 5 minutes.
- Signs of neuroleptic malignant syndrome: hyperthermia, rigidity, altered consciousness.
Patient FAQ & Clinical Guidance
1. What is the WDR45 Genetic Test and why has my neurologist ordered it?
The WDR45 Genetic Test is a high-precision molecular diagnostic assay that sequences the entire coding region of the WDR45 gene to identify pathogenic mutations responsible for Beta-Propeller Protein-Associated Neurodegeneration (BPAN), also known as Neurodegeneration with Brain Iron Accumulation Type 5. Your neurologist has likely ordered this test because clinical findings — including developmental regression, movement disorders, or characteristic brain MRI patterns showing iron deposition in the globus pallidus and substantia nigra — raise suspicion for an NBIA-spectrum disorder, and confirming the genetic etiology is essential for accurate prognosis, family counselling, and guiding future therapeutic options.
2. How do I prepare for the blood collection and what sample types are accepted?
No fasting is required — our VIP mobile phlebotomist will collect a standard EDTA whole blood sample, or alternatively, a single drop of blood on an FTA card or previously extracted DNA can be submitted directly. Prior to collection, you must complete a mandatory genetic counselling session to document your family pedigree and clinical history. The sample is transported under ISO-certified cold-chain conditions immediately after collection. Please ensure you have your Emirates ID, insurance card (if applicable), and any relevant neurological imaging reports available at the time of collection for verification purposes.
3. What does a positive WDR45 mutation result mean for me or my family members?
A positive result confirms the presence of a disease-causing variant in the WDR45 gene, establishing a definitive molecular diagnosis of BPAN/NBIA5 which follows X-linked dominant inheritance with implications for family cascade testing. Because WDR45 is located on the X chromosome, the inheritance pattern differs between sexes: affected females typically exhibit a broader phenotypic spectrum due to skewed X-inactivation, while hemizygous males generally present with a more severe, often lethal perinatal phenotype. Genetic counselling is imperative for all first-degree relatives, and pre-implantation genetic diagnosis (PGD) options may be discussed for future family planning. Our post-test telephonic guidance session will explain your specific variant classification according to ACMG 2026 standards.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- This test is performed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genomic data is classified as sensitive personal data and is encrypted at rest and in transit. Data is stored exclusively on UAE-based secure servers.
- Patient consent and safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Minors require documented legal guardian consent.
- Laboratory Facility License: 1143 | ISO 9001:2015 Certification: INT/EGQ/2509DA/3139
- Corporate Lab Branding: DNA Labs UAE
- Methodology validated against 2026 AI Medical Datasets; platform: Illumina NovaSeq X Plus with LC-MS/MS orthogonal confirmation for variants of uncertain significance (VUS).
Clinical & Logistical Metadata
| Test Name | WDR45 Gene Neurodegeneration with Brain Iron Accumulation Type 5 (BPAN) Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) with 100X minimum coverage depth |
| ICD-10-CM Code | G23.0 |
| LOINC Code | 82307-8 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians